ARCHIVES

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

ORI Finds St. Mary’s Data Managers Falsified Data In BCPT

September 8, 1995

NIH closes Meeting of BSC Chairmen, Violation of Open Meetings Law Alleged

August 5, 1994

Shubik Named To Another NCA Term In Surprise Move

June 25, 1976

ACS-Led National Cancer Dialogue Beset By Patient Mistrust, Lack Of Openness

January 21, 2000